網頁

星期日, 2月 12, 2017

三機構 3/5 合辦生涯規劃系列座談

Advertisement in the newsletter of Lexington Chinese School
Chinese:

新英格蘭玉山科技協會紐英崙中華專業人員協會大波士頓地區台大校友會敬邀您參加三會聯合主辦的生涯規劃系列座談會」(Career Planning Panel Discussions),此次座談會的主題是如何突破玻璃天花板 - 管理經驗談 (How to break through the glass ceiling – Management Experience Sharing),希望您能參加。
講者 (Panelists):
Ø  宋晶晶Dr. Crystal Sung, Scientific Director of Clinical Diagnostic, Sanofi
Ø  林俐伶 Dr. Lih-Ling, Senior Director, Inflammation and Immunology Research Unit, Pfizer
Ø  曹伯禹 Dr. Bor-Yeu Tsaur, Executive Vice President, Kopin Corporation
Ø  蔣宗壬 Dr. Edward Chiang, President, H2O Engineering Consulting

時間: March 5 (Sunday), 下午2-4
地點: Lexington Chinese School, Little Theatre (221 Concord Ave., Belmont, MA)
語言:中文主講,中英文討論

English:
Monte Jade Science and Technology Association of New England, New England Association of Chinese Professionals, and Greater Boston Alumni Association of National Taiwan University invite you to participate in the panel discussion: How to break the glass ceiling – management experience sharing.
Panelists:
Ø  宋晶晶Dr. Crystal Sung, Scientific Director of Clinical Diagnostic, Sanofi
Ø  林俐伶 Dr. Lih-Ling, Senior Director, Inflammation and Immunology Research Unit, Pfizer
Ø  曹伯禹 Dr. Bor-Yeu Tsaur, Executive Vice President, Kopin Corporation
Ø  蔣宗壬 Dr. Edward Chiang, President, H2O Engineering Consulting

Time: March 5 (Sunday), 2-4pm
Location: Lexington Chinese School, Little Theatre (221 Concord Ave., Belmont, MA)
Language: Chinese for presentation, Chinese/English for discussion

Panelists

Dr. Crystal Sung 宋晶晶is a Sr. Scientific Director, head of Clinical Diagnostics at Sanofi.  She has over 15 years of industry experience in biologics development with scientific expertise to support global R&D projects. Crystal holds a Ph.D. degree in Pathology from The Ohio State University, College of Medicine and a BS in Medical Technology from National Taiwan University.  She completed her post-doctoral trainings at Northwestern University Medical School followed by Clinical Immunology Fellowship at Children’s Memorial Hospital in Chicago.  Prior to joining Biotech Pharma industry, she was an Assistant Professor in Tzu-Chi Medical School, Taiwan.
Crystal is a member of AAPS, AMLI and AACC. She recently joined AAPS TPIFG pre-existing antibody working group and ADA Clinical Relevance APA team.

Crystal Sung is a Diplomate of American Board of Medical Laboratory Immunology (ABMLI) and currently holds CLIA high complexity lab directorship and New York State Department of Public Health certificate of laboratory director in Diagnostic Immunology and Clinical Chemistry.  Crystal serves as Board of directors, Mount Jade Science and Technology Association of New England.

Dr. Lih-Ling Lin林俐伶 is a Senior Director in Pfizer. She leads the Discovery Innate Immunity effort dedicated in the emerging science for the drug discovery effort in the Inflammation and Immunology Research Unit. 

Lih-Ling graduated from National Taiwan University with a undergraduate degree in Pharmacy and Master degree in Biochemistry. She then went to University of Arizona for her graduate work, and received her PhD degree in Biochemistry.  Lih-Ling Lin joined Wyeth (Genetics Institute) and contributed to the discovery of several PLC  and cPLA2 family members. She then led a discovery team targeting the signal transduction pathways in innate immunity involved in the production of inflammatory mediators and cytokines (e.g. TNF).  These projects include development of  kinase inhibitors and Biologics targeting innate receptors and cytokines. This effort has led to the discovery of clinical candidates in treating autoimmune and inflammatory diseases such as rheumatoid arthritis and Inflammatory Bowel disease.  Lih-Ling is an author of over 70 scientific papers and patents. 

Dr. Boryeu Tsaur 曹伯禹received the BSEE degree from National Taiwan University in 1977, the MS degree from Caltech (California Institute of technology) in 1978, and the Ph D degree also from Caltech in 1980. He Joined MIT Lincoln Laboratory and quickly established himself as the most productive research staff member in the Solid State Division. He subsequently served as the leader of Electronics Material group and was the youngest Group Leader in the Lab. He joined Kopin in 1997 as Executive Vice President and General Manager, responsible for the Display Business unit. Under his leadership, Kopin has become one of the most successful display technology and product companies in US. Kopin is the leader in the emerging field of AR (Augmented Reality) and VR (virtual Reality) with a wide range of display products.


Dr. Edward Chiang蔣宗壬
·       學歷﹕中原理工大學水利工程系學士、維基尼亞理工大學土木系碩士、博士
·       經歷﹕M & E, Inc; 資深工程師查理士‧銘公司、領導工程師惠德曼、哈維公司副總裁兼水利總工程師水利顧問工程公司總裁。
·       其它經歷﹕先峰電子公司董事,董事長波士頓美洲銀行董事,董事長紐英崙醫療中心董事,麻省環保署顧問委員會委員。
社區服務﹕曾任大波士頓文化協會主席董事紐英崙中華專業人員協會主席、董事長紐英崙玉山科技協會創辦人波士頓南彎區及中國城小議會共同議長中華公所議員。現任﹕華人經濟發展協會董事長紐英崙專業人員協會顧問。